In a recent study in patients who were equally at risk for CAD based on traditional biomarkers and who were then diagnosed as either having CAD or not using diagnostic coronary arteriography, ApoA-II was significantly lower in CAD patients compared to patients without CAD (7). Here, APOA2 is linked to coronary artery disorder.